Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer

Launched by LUDWIG-MAXIMILIANS - UNIVERSITY OF MUNICH · Nov 2, 2018

Keywords

ClinConnect Summary

This clinical trial is looking at how treatments for rectal cancer, specifically neoadjuvant radiation or chemoradiation followed by surgery, affect patients' quality of life. Researchers want to understand how these treatments impact not just the cancer itself but also how patients feel and function in their daily lives after treatment. They will use standardized questionnaires to gather information about patients’ experiences and any side effects they may have during and after the treatment process.

To be eligible for this study, participants must be at least 18 years old and have a confirmed diagnosis of rectal cancer that has not spread to other parts of the body. They should also be recommended for neoadjuvant radiation or chemoradiation therapy by a team of doctors. Participants will need to provide written consent and be able to answer questions about their health and quality of life. The study is currently recruiting participants, and it aims to help improve understanding of how these treatments affect patients over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • histologically proven rectal Cancer without distant metastases
• • indication for neoadjuvant Radiation or chemoradiation therapy according to multidiciplinary Evaluation
• • age \>=18 years
• • written informed consent
• • ability to answer the standardized questionaires according to the treating physician
• Exclusion Criteria:
• • age \< 18 years
• • prior systemic therapy with regard to rectal Cancer
• • distant metastasis
• • second malignancy